Find a Trial
Trial Summary
| Protocol No. | RAON-IIR-IUSCC-0710 | ||
|---|---|---|---|
| Status | OPEN TO ACCRUAL | ||
| Principal Investigator | Shiue, Kevin | ||
| Scope | Local | ||
| Phase | NA | ||
| Age Group | Adult | ||
| Title | Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study | ||
| Description | To evaluate objective response rates of brain metastasis after ICI concurrent with SRS at six months with regard to symptomatic radiation necrosis, defined as an actuarial 6-month rate of clinical symptomatology requiring steroid administration (i.e. Decadron), bevacizumab (Avastin), and/or operative intervention concomitant with advanced and routine brain imaging findings consistent with radiation necrosis. | ||
| Key Eligibility | In order to be eligible to take part in this trial, patients must have:
| ||
| Applicable Disease Sites | Brain and Nervous System | ||
| Participating Institutions | Indiana University (IU) | ||
| Treatment Type | Treatment | ||
| Contact | Phone: (317) 278-5632 Email: iutrials@iu.edu | ||